Simplex Trading
TAK icon

Simplex Trading’s Takeda Pharmaceutical TAK Stock Holding History

Simplex Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
7,700
+5,700
+285% +$94.3K ﹤0.01% 5294
2026
Q1 		$37K Buy
+2,000
New +$35.1K ﹤0.01% 6174
2025
Q4 		– Sell
-6,500
Closed -$95K – 10024
2025
Q3 		$95K Sell
6,500
-9,300
-59% -$138K ﹤0.01% 5809
2025
Q2 		$244K Buy
15,800
+11,100
+236% +$164K ﹤0.01% 4296
2025
Q1 		$69K Buy
4,700
+800
+21% +$11.2K ﹤0.01% 5471
2024
Q4 		$51K Sell
3,900
-1,300
-25% -$17.9K ﹤0.01% 5858
2024
Q3 		$73K Buy
5,200
+2,600
+100% +$36.9K ﹤0.01% 5530
2024
Q2 		$33K Sell
2,600
-11,500
-82% -$152K ﹤0.01% 6483
2024
Q1 		$195K Sell
14,100
-246,200
-95% -$3.58M ﹤0.01% 4890
2023
Q4 		$3.71M Buy
260,300
+1,300
+0.5% +$18.4K ﹤0.01% 1811
2023
Q3 		$4.01M Buy
259,000
+240,500
+1,300% +$3.72M ﹤0.01% 1494
2023
Q2 		$290K Sell
18,500
-6,500
-26% -$107K ﹤0.01% 3898
2023
Q1 		$412K Sell
25,000
-225,800
-90% -$3.6M ﹤0.01% 3471
2022
Q4 		$3.91M Buy
250,800
+24,800
+11% +$346K ﹤0.01% 1368
2022
Q3 		$2.93M Buy
226,000
+7,900
+4% +$110K ﹤0.01% 1636
2022
Q2 		$3.06M Buy
218,100
+8,300
+4% +$118K ﹤0.01% 1486
2022
Q1 		$3M Buy
209,800
+185,400
+760% +$2.72M ﹤0.01% 1699
2021
Q4 		$332K Buy
24,400
+1,100
+5% +$15.4K ﹤0.01% 4397
2021
Q3 		$393K Sell
23,300
-100
-0.4% -$1.68K ﹤0.01% 4477
2021
Q2 		$393K Buy
23,400
+22,712
+3,301% +$387K ﹤0.01% 4539
2021
Q1 		$1.26M Buy
688
+10
+1% +$180 ﹤0.01% 2146
2020
Q4 		$1.23M Buy
678
+145
+27% +$2.54K ﹤0.01% 2294
2020
Q3 		$950K Buy
533
+114
+27% +$2.08K ﹤0.01% 2280
2020
Q2 		$750K Sell
419
-91
-18% -$1.63K ﹤0.01% 2422
2020
Q1 		$773K Buy
+510
New +$9.24K ﹤0.01% 2129
2019
Q1 		– Sell
-13
Closed -$21K – 7818
2018
Q4 		$21K Buy
+13
New +$219 ﹤0.01% 5289

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading's TAK Position: Q2 2026 in Review

Simplex Trading sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 5,146 shares — an estimated $85.2K sold.

Simplex Trading first reported a position in TAK in Q3 2019 and held it in 9 quarters. The position peaked at $535K in Q2 2021. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Simplex Trading reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 5,146 Takeda Pharmaceutical shares in Q2 2026, an estimated $85.2K.
  • Simplex Trading first reported a position in Takeda Pharmaceutical in Q3 2019 and held it in 9 quarters.
  • Simplex Trading's Takeda Pharmaceutical position peaked at $535K in Q2 2021.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.